Literature DB >> 19951947

Determinants for the rhesus monkey TRIM5alpha-mediated block of the late phase of HIV-1 replication.

Ryuta Sakuma1, Seiga Ohmine, Yasuhiro Ikeda.   

Abstract

Rhesus monkey TRIM5alpha (TRIM5alpharh) includes RING, B-box, coiled-coil, and B30.2(PRYSPRY) domains and blocks HIV-1 infection by targeting HIV-1 core through a B30.2(PRYSPRY) domain. Previously, we reported that TRIM5alpharh also blocks HIV-1 production in a B30.2(PRYSPRY)-independent manner. Efficient encapsidation of TRIM5alpharh, but not human TRIM5alpha (TRIM5alphahu), in HIV-1 virus-like particles suggests the interaction between Gag and TRIM5alpharh during viral assembly. Here, we determined responsible regions for late restriction activity of TRIM5alpharh. The RING disruption, but not the replacement with human TRIM21 RING, ablated the efficient encapsidation and the late restriction, suggesting that a RING structure was essential for the late restriction and efficient interaction with HIV-1 Gag. The prominent cytoplasmic body formation of TRIM5alpharh, which depended on the coiled-coil domain and the ensuing linker 2 region, was not required for the encapsidation. Intriguingly, TRIM5alpharh coiled-coil domain mutants (M133T and/or T146A) showed impaired late restriction activity, despite the efficient encapsidation and cytoplasmic body formation. Our results suggest that the TRIM5alpharh-mediated late restriction involves at least two distinct activities as follows: (i) interaction with HIV-1 Gag polyprotein through the N-terminal, RING, and B-box 2 regions of a TRIM5alpharh monomer, and (ii) an effector function(s) that depends upon the coiled-coil and linker 2 domains of TRIM5alpharh. We speculate that the TRIM5alpharh coiled-coil region recruits additional factor(s), such as other TRIM family proteins or a cellular protease, during the late restriction. RBCC domains of TRIM family proteins may play a role in sensing newly synthesized viral proteins as a part of innate immunity against viral infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19951947      PMCID: PMC2823520          DOI: 10.1074/jbc.M109.059063

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Retroviral restriction factor TRIM5alpha is a trimer.

Authors:  Claudia C Mische; Hassan Javanbakht; Byeongwoon Song; Felipe Diaz-Griffero; Matthew Stremlau; Bettina Strack; Zhihai Si; Joseph Sodroski
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.

Authors:  David Perez-Caballero; Theodora Hatziioannou; Annie Yang; Simone Cowan; Paul D Bieniasz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.

Authors:  Byeongwoon Song; Hassan Javanbakht; Michel Perron; Do Hyun Park; Matthew Stremlau; Joseph Sodroski
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.

Authors:  Hassan Javanbakht; Felipe Diaz-Griffero; Matthew Stremlau; Zhihai Si; Joseph Sodroski
Journal:  J Biol Chem       Date:  2005-05-15       Impact factor: 5.157

6.  Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Authors:  A Mörner; A Björndal; J Albert; V N Kewalramani; D R Littman; R Inoue; R Thorstensson; E M Fenyö; E Björling
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.

Authors:  B Chesebro; K Wehrly; J Nishio; S Perryman
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes.

Authors:  M Simm; M Shahabuddin; W Chao; J S Allan; D J Volsky
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.

Authors:  Melvyn W Yap; Sébastien Nisole; Jonathan P Stoye
Journal:  Curr Biol       Date:  2005-01-11       Impact factor: 10.834

10.  The tripartite motif family identifies cell compartments.

Authors:  A Reymond; G Meroni; A Fantozzi; G Merla; S Cairo; L Luzi; D Riganelli; E Zanaria; S Messali; S Cainarca; A Guffanti; S Minucci; P G Pelicci; A Ballabio
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

View more
  8 in total

1.  Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.

Authors:  Seiga Ohmine; Ryuta Sakuma; Toshie Sakuma; Tayaramma Thatava; Gonzalo P Solis; Yasuhiro Ikeda
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

Review 2.  Ex vivo gene therapy for HIV-1 treatment.

Authors:  Lisa J Scherer; John J Rossi
Journal:  Hum Mol Genet       Date:  2011-04-19       Impact factor: 6.150

3.  The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.

Authors:  Seiga Ohmine; Ryuta Sakuma; Toshie Sakuma; Tayaramma Thatava; Hiroaki Takeuchi; Yasuhiro Ikeda
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

4.  Role of Human TRIM5α in Intrinsic Immunity.

Authors:  Emi E Nakayama; Tatsuo Shioda
Journal:  Front Microbiol       Date:  2012-03-15       Impact factor: 5.640

5.  Suppressor of cytokine signaling 1 counteracts rhesus macaque TRIM5α-induced inhibition of human immunodeficiency virus type-1 production.

Authors:  Sayaka Sukegawa; Ryuta Sakuma; Seiga Ohmine; Hiroaki Takeuchi; Yasuhiro Ikeda; Shoji Yamaoka
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

Review 6.  How HIV-1 Gag Manipulates Its Host Cell Proteins: A Focus on Interactors of the Nucleocapsid Domain.

Authors:  Jéromine Klingler; Halina Anton; Eléonore Réal; Manon Zeiger; Christiane Moog; Yves Mély; Emmanuel Boutant
Journal:  Viruses       Date:  2020-08-13       Impact factor: 5.048

Review 7.  Molecular mechanism of arenavirus assembly and budding.

Authors:  Shuzo Urata; Jiro Yasuda
Journal:  Viruses       Date:  2012-10-10       Impact factor: 5.048

8.  Production of Vesicular Stomatitis Virus Glycoprotein-Pseudotyped Lentiviral Vector Is Enhanced by Ezrin Silencing.

Authors:  Mai Izumida; Kei Togawa; Hideki Hayashi; Toshifumi Matsuyama; Yoshinao Kubo
Journal:  Front Bioeng Biotechnol       Date:  2020-04-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.